1. Be able to determine the risk of malignancy of an adrenal mass and any adrenal hormone excess that would support a “primary” adrenal process: functional and/or anatomical / benign or malignant.
2. Understand the role of genetics in the pathobiology of adrenal cancer and to discuss how such knowledge is transforming how we care for our patients.
01/30/2023 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Gary Hammer, M.D., Ph.D.